- This event has passed.
Herding Cats 3.0: Big Pharma Panel
What does it really take to build a successful strategic partnership in life sciences? For today’s business development leaders, identifying which opportunities will genuinely help accelerate growth can be challenging.
In this dynamic program, attendees will hear from Johnson & Johnson’s External Innovation Group deal-making experts, who will provide strategic guidance on core collaboration capabilities such as:
- Partnership lifecycle management
- Valuation fundamentals
- Negotiation and communication strategies
Following the main presentation, attendees will be invited to join an exclusive panel discussion featuring Lesley Stolz, Head of West North America, External Scientific Innovation, Johnson & Johnson, alongside additional Big Pharma representatives, who will share how established organizations evaluate partnership opportunities and what emerging companies should understand when engaging with large pharmaceutical partners.
Designed specifically for business development professionals, life science innovators, and startup founders in oncology, immunology, and neuroscience, this event will deliver practical knowledge to help maximize meaningful collaborations in 2026 and beyond.
Please note: This is an apply-to-attend event. The application deadline is March 11th, and approved attendees will be notified by March 16.
Hosted by:
